Generation Bio Co.
Generation Bio Co. (GBIO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GBIO · as of Jun 9, 2026
Key Statistics
Explore Generation Bio Co. Data
gbio stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 50.0%
The GBIO analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $5.25, representing -1.69% downside from the current price of $5.34.
Competitors & Peers
gbio competitorsGBIO
BOLD
BTAI
CELU
EVAX
JSPRStock Performance
Full HistoryAbout Generation Bio Co.
Generation Bio Co. is a biotechnology firm focused on genetic therapies, working to devise treatments for both uncommon and widespread diseases. The company's current development pipeline includes mul…
what is generation bio co. · gbio stock overview · generation bio co. company profile · who is generation bio co. ceo · gbio NASDAQ · generation bio co. headquarters · generation bio co. business segments
About Stock Overview & Key Data
Generation Bio Co. (GBIO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 12, 2020. As of the latest trading session, GBIO stock price is $5.34, with a market capitalization of $36.0M. The stock has returned +1.71% over the past 12 months and -2.02% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Generation Bio Co. stock is Buy, with an average 12-month price target of $5.25. In fiscal year 2024, Generation Bio Co. reported revenue of $19.9M and net income of -$131.7M. For detailed data — including Generation Bio Co. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Generation Bio Co. (GBIO) stock price is $5.34. The stock is traded on NASDAQ under the ticker symbol GBIO. The 52-week range is $3.00 – $7.52.